Antimony

DB13110InvestigationalSmall molecule

Antimony has been used in trials studying the treatment of Cutaneous Leishmaniasis.

Chemical structure of Antimony
Formula / weight
Sb · 121.76 g/mol (avg)

Resolves to

Compound
UNII9IT35J3UV3CAS7440-36-0ChEBI30513PubChem5354495
Clinical / RWD
RxNorm1311407
Structure
InChIKeyWATWJIUSRGPENY-UHFFFAOYSA-NSMILES[Sb]
Targets
O75762TRPA1P08690arsAP56545CTBP2
Transporters
P33527ABCC1P0AER0glpF

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Antimony, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In